Choi, H.S.; Ko, Y.S.; Jin, H.; Kang, K.M.; Ha, I.B.; Jeong, H.; Song, H.-N.; Kim, H.J.; Jeong, B.K.
Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro. Molecules 2021, 26, 5118.
https://doi.org/10.3390/molecules26175118
AMA Style
Choi HS, Ko YS, Jin H, Kang KM, Ha IB, Jeong H, Song H-N, Kim HJ, Jeong BK.
Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro. Molecules. 2021; 26(17):5118.
https://doi.org/10.3390/molecules26175118
Chicago/Turabian Style
Choi, Hoon Sik, Young Shin Ko, Hana Jin, Ki Mun Kang, In Bong Ha, Hojin Jeong, Haa-Na Song, Hye Jung Kim, and Bae Kwon Jeong.
2021. "Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro" Molecules 26, no. 17: 5118.
https://doi.org/10.3390/molecules26175118
APA Style
Choi, H. S., Ko, Y. S., Jin, H., Kang, K. M., Ha, I. B., Jeong, H., Song, H.-N., Kim, H. J., & Jeong, B. K.
(2021). Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro. Molecules, 26(17), 5118.
https://doi.org/10.3390/molecules26175118
